Skip to main content
. 2019 Jul 16;20(10):1319–1327. doi: 10.1080/15384047.2019.1638670

Figure 4.

Figure 4.

Immunohistochemistry and survival curves of KMT2D and TET2 in ENKTL patients. (a), Immunohistochemistry of KMT2D. (b), Immunohistochemistry of TET2. (c), survival curves of ENKTL patients according to KMT2D and TET gene mutation or protein loss of function.